| 1 |
Jiang Z, Zhang W, Zhang Z, Sha G, Wang D, Tang D. Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer. Cancer Lett 2023;554:216031. [PMID: 36481214 DOI: 10.1016/j.canlet.2022.216031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Asili P, Mirahmad M, Rezaei P, Mahdavi M, Larijani B, Tavangar SM. The Association of Oral Microbiome Dysbiosis with Gastrointestinal Cancers and Its Diagnostic Efficacy. J Gastrointest Cancer 2023. [PMID: 36600023 DOI: 10.1007/s12029-022-00901-4] [Reference Citation Analysis]
|
| 3 |
Pfisterer N, Lingens C, Heuer C, Dang L, Neesse A, Ammer-Herrmenau C. The Microbiome in PDAC-Vantage Point for Future Therapies? Cancers (Basel) 2022;14. [PMID: 36497456 DOI: 10.3390/cancers14235974] [Reference Citation Analysis]
|
| 4 |
Mattos VC, Nascimento FSD, Suzuki MO, Taba JV, Pipek LZ, Moraes WAF, Cortez VS, Kubrusly MS, Torsani MB, Iuamoto L, Hsing WT, Carneiro-D'Albuquerque LA, Meyer A, Andraus W. MICRObiota on BILIOpancreatic malignant diseases [MICROBILIO]: A systematic review. Clinics (Sao Paulo) 2022;77:100101. [PMID: 36122499 DOI: 10.1016/j.clinsp.2022.100101] [Reference Citation Analysis]
|
| 5 |
Zheng HH, Du CT, Yu C, Tang XY, Huang RL, Zhang YZ, Gao W, Xie GH. The Relationship of Tumor Microbiome and Oral Bacteria and Intestinal Dysbiosis in Canine Mammary Tumor. Int J Mol Sci 2022;23:10928. [PMID: 36142841 DOI: 10.3390/ijms231810928] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 6 |
D’antonio DL, Marchetti S, Pignatelli P, Piattelli A, Curia MC. The Oncobiome in Gastroenteric and Genitourinary Cancers. IJMS 2022;23:9664. [DOI: 10.3390/ijms23179664] [Reference Citation Analysis]
|
| 7 |
Fang Y, Yang G, Yang J, Ren J, You L, Zhao Y. Human microbiota colonization and pancreatic ductal carcinoma. Crit Rev Microbiol 2022;:1-14. [PMID: 35924947 DOI: 10.1080/1040841X.2022.2080526] [Reference Citation Analysis]
|
| 8 |
Amara S, Yang LV, Tiriveedhi V, Muzaffar M. Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications. Cells 2022;11:1900. [PMID: 35741028 DOI: 10.3390/cells11121900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Kabwe M, Dashper S, Tucci J. The Microbiome in Pancreatic Cancer-Implications for Diagnosis and Precision Bacteriophage Therapy for This Low Survival Disease. Front Cell Infect Microbiol 2022;12:871293. [DOI: 10.3389/fcimb.2022.871293] [Reference Citation Analysis]
|
| 10 |
Zhang Z, Tang D. The huge clinical potential of microbiota in the treatment of pancreatic cancer: The next frontier. Biochim Biophys Acta Rev Cancer 2022;1877:188733. [PMID: 35483491 DOI: 10.1016/j.bbcan.2022.188733] [Reference Citation Analysis]
|
| 11 |
Bakadia BM, Manan S, Ul-islam M, Mukole BM, Shahzad A, Abdalla AME, Ullah MW, Yang G. Microbiome as Cancer Biomarkers. Cancer Biomarkers in Diagnosis and Therapeutics 2022. [DOI: 10.1007/978-981-16-5759-7_5] [Reference Citation Analysis]
|
| 12 |
Proc P, Szczepańska J, Zarzycka B, Szybka M, Borowiec M, Płoszaj T, Fendler W, Chrzanowski J, Zubowska M, Stolarska M, Młynarski W. Evaluation of Changes to the Oral Microbiome Based on 16S rRNA Sequencing among Children Treated for Cancer. Cancers 2021;14:7. [DOI: 10.3390/cancers14010007] [Reference Citation Analysis]
|
| 13 |
Huang X, Li M, Hou S, Tian B. Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review). Int J Oncol 2021;59:101. [PMID: 34738624 DOI: 10.3892/ijo.2021.5281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Li JJ, Zhu M, Kashyap PC, Chia N, Tran NH, McWilliams RR, Bekaii-Saab TS, Ma WW. The role of microbiome in pancreatic cancer. Cancer Metastasis Rev 2021;40:777-89. [PMID: 34455517 DOI: 10.1007/s10555-021-09982-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 15 |
Wei LQ, Cheong IH, Yang GH, Li XG, Kozlakidis Z, Ding L, Liu NN, Wang H. The Application of High-Throughput Technologies for the Study of Microbiome and Cancer. Front Genet 2021;12:699793. [PMID: 34394190 DOI: 10.3389/fgene.2021.699793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Jiang Z, Li L, Chen J, Wei G, Ji Y, Chen X, Liu J, Huo J. Human gut-microbiome interplay: Analysis of clinical studies for the emerging roles of diagnostic microbiology in inflammation, oncogenesis and cancer management. Infect Genet Evol 2021;93:104946. [PMID: 34052417 DOI: 10.1016/j.meegid.2021.104946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
